JP2007503433A5 - - Google Patents

Download PDF

Info

Publication number
JP2007503433A5
JP2007503433A5 JP2006524614A JP2006524614A JP2007503433A5 JP 2007503433 A5 JP2007503433 A5 JP 2007503433A5 JP 2006524614 A JP2006524614 A JP 2006524614A JP 2006524614 A JP2006524614 A JP 2006524614A JP 2007503433 A5 JP2007503433 A5 JP 2007503433A5
Authority
JP
Japan
Prior art keywords
composition
oil
acid
active compound
pharmaceutically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006524614A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007503433A (ja
Filing date
Publication date
Priority claimed from US10/650,262 external-priority patent/US20050049210A1/en
Application filed filed Critical
Publication of JP2007503433A publication Critical patent/JP2007503433A/ja
Publication of JP2007503433A5 publication Critical patent/JP2007503433A5/ja
Withdrawn legal-status Critical Current

Links

JP2006524614A 2003-08-27 2004-04-16 医薬的に活性な化合物の制御された送達方法 Withdrawn JP2007503433A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/650,262 US20050049210A1 (en) 2003-08-27 2003-08-27 Methods for the controlled delivery of pharmacologically active compounds
PCT/US2004/011823 WO2005025488A2 (en) 2003-08-27 2004-04-16 Methods for the controlled delivery of pharmacologically active compounds

Publications (2)

Publication Number Publication Date
JP2007503433A JP2007503433A (ja) 2007-02-22
JP2007503433A5 true JP2007503433A5 (https=) 2007-06-07

Family

ID=34217115

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006524614A Withdrawn JP2007503433A (ja) 2003-08-27 2004-04-16 医薬的に活性な化合物の制御された送達方法

Country Status (7)

Country Link
US (1) US20050049210A1 (https=)
EP (1) EP1667654A2 (https=)
JP (1) JP2007503433A (https=)
AU (1) AU2004271909A1 (https=)
BR (1) BRPI0413883A (https=)
CA (1) CA2535373A1 (https=)
WO (1) WO2005025488A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003034988A2 (en) * 2001-10-19 2003-05-01 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
CN101983632A (zh) * 2010-10-11 2011-03-09 西北农林科技大学 一种复方替米考星纳米乳抗菌药物及其制备方法
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
WO2014126969A1 (en) 2013-02-12 2014-08-21 Bend Research, Inc. Solid dispersions of low-water solubility actives
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103463480A (zh) * 2013-08-22 2013-12-25 邢波 一种治疗经络阻塞型急性颈部淋巴结炎的中药制备方法
JP6698669B2 (ja) * 2015-02-09 2020-05-27 セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ 粘膜炎の治療のための組成物及び方法
CN107184553A (zh) * 2017-06-14 2017-09-22 天津佰力喜动物药业有限公司 一种替米考星脂质体分散剂的制备方法
CN108392467A (zh) * 2018-05-30 2018-08-14 山东德信生物科技有限公司 一种替米考星注射液及其制备方法
CN109077999A (zh) * 2018-08-31 2018-12-25 田红卫 一种长效缓释替米考星注射液及其制备方法
CN109655534B (zh) * 2018-11-08 2021-11-30 佛山市正典生物技术有限公司 一种替米考星颗粒含量的检测方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US28875A (en) * 1860-06-26 Improvement in desulphurizing ores and coal
ES8104203A1 (es) * 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
US4361557A (en) * 1980-01-28 1982-11-30 Schering Corporation 1-Aryl-2-acylamido-3-fluoro-1-propanol acylates, methods for their use as anti-bacterial agents and compositions useful therefor
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4876352A (en) * 1988-09-14 1989-10-24 Schering Corporation Pressurized fluorination of hydroxy alkyl groups
US5574020A (en) * 1989-09-28 1996-11-12 Eli Lilly And Company Tilmicosin formulation
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
CZ286239B6 (cs) * 1990-10-25 2000-02-16 Schering Corporation Způsob přípravy florfenikolu, jeho analogy a oxazolinové meziprodukty
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5352832A (en) * 1992-12-18 1994-10-04 Schering Corporation Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
CA2176709A1 (en) * 1993-11-15 1995-05-26 Howard R. Higley Method of treating renal disease by administering igf-i and igfbp-3
US6110905A (en) * 1994-07-09 2000-08-29 Norbrook Laboratories Limited Long-acting oxytetracycline composition
US6333021B1 (en) * 1994-11-22 2001-12-25 Bracco Research S.A. Microcapsules, method of making and their use
US6310053B1 (en) * 1995-07-05 2001-10-30 Norbrook Laboratories Limited Long-acting oxytetracycline composition
US5723447A (en) * 1996-07-02 1998-03-03 Rhone Merieux, Inc. Water miscible erythromycin solutions
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US5663361A (en) * 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5766506A (en) * 1996-09-12 1998-06-16 The Dow Chemical Company Hard water compatible phosphate-containing heat transfer fluids
SE511313C2 (sv) * 1997-01-13 1999-09-06 Gs Dev Ab Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US5977133A (en) * 1998-08-19 1999-11-02 Abbott Laboratories Pyridone antibiotic with improved safety profile
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
WO2003034988A2 (en) * 2001-10-19 2003-05-01 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
ATE374602T1 (de) * 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität

Similar Documents

Publication Publication Date Title
RU2004115103A (ru) Инъецируемые композиции для контролируемоей доставки фармакологически активного соединения
JP2005506992A5 (https=)
JP2007503433A5 (https=)
KR950002150B1 (ko) 레보도파 메틸에스테르를 함유하는 제약 조성물
JP2004532272A5 (https=)
RU2009118960A (ru) Комбинации ацетаминофена/ибуппрофена
BRPI0618891A2 (pt) composições farmacêuticas
CN1301147A (zh) 可用于牙周的胶凝药物组合物
CN1652783A (zh) 治疗牛和猪感染的组合物及方法
RU2002103873A (ru) Пероральные жидкие композиции
JP2005512995A5 (https=)
JP2010513500A5 (https=)
JP2003508484A5 (https=)
RU2009127500A (ru) Фармацевтические композиции и способ лечения воспаления у крупного рогатого скота и других животных
JP2018515463A5 (https=)
CA2522009A1 (en) Methods for the controlled delivery of pharmacologically active compounds
JP2014530842A5 (https=)
WO2005025488A3 (en) Methods for the controlled delivery of pharmacologically active compounds
EP3082762B1 (en) Long-acting ketoprofen compositions
JP2006523723A5 (https=)
JP2024544415A5 (https=)
RU96124084A (ru) Трансдермальное введение противоэпилептических лекарственных препаратов
RU2017145643A (ru) Фармацевтические композиции для пролонгированного высвобождения себакоил-диналбуфинового эфира
RU2003115093A (ru) Болеутоляющие композиции, содержащие ненаркотический анальгетик и усилитель анальгезии
JP2008533135A (ja) ゲムシタビン誘導体の経口投薬形態